Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
|Product:||0.9% Sodium Chloride Injection|
|Active Ingredient:||Sodium chloride 0.9%w/v|
|Dosage Form:||Solution for infusion|
|New Zealand Sponsor:||Baxter Healthcare Limited|
|Manufacturer:||Baxter S.A. de C.V., Jiutepec, Mexico|
|Note: This consent is valid for two years from the date of publication of this notice.|
Dated this 6th day of July 2020.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).